150 related articles for article (PubMed ID: 14600569)
1. Phenotype and functional characteristics of HIV-specific cytotoxic CD8+ T cells in chronically infected patients: dual effects of highly active antiretroviral therapy.
Benito JM; López M; Lozano S; Martinez P; Kuroda M; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2003 Nov; 34(3):255-66. PubMed ID: 14600569
[TBL] [Abstract][Full Text] [Related]
2. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope.
Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M
J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263
[TBL] [Abstract][Full Text] [Related]
3. Impact of Gag sequence variability on level, phenotype, and function of anti-HIV Gag-specific CD8(+) cytotoxic T lymphocytes in untreated chronically HIV-infected patients.
López M; Soriano V; Lozano S; Martinez P; Sempere J; González-Lahoz J; Benito J
AIDS Res Hum Retroviruses; 2006 Sep; 22(9):884-92. PubMed ID: 16989614
[TBL] [Abstract][Full Text] [Related]
4. Anti-human immunodeficiency virus type 1 (HIV-1) CD8(+) T-lymphocyte reactivity during combination antiretroviral therapy in HIV-1-infected patients with advanced immunodeficiency.
Rinaldo CR; Huang XL; Fan Z; Margolick JB; Borowski L; Hoji A; Kalinyak C; McMahon DK; Riddler SA; Hildebrand WH; Day RB; Mellors JW
J Virol; 2000 May; 74(9):4127-38. PubMed ID: 10756025
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups.
Mollet L; Li TS; Samri A; Tournay C; Tubiana R; Calvez V; Debré P; Katlama C; Autran B
J Immunol; 2000 Aug; 165(3):1692-704. PubMed ID: 10903781
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection.
Feeney ME; Draenert R; Roosevelt KA; Pelton SI; McIntosh K; Burchett SK; Mao C; Walker BD; Goulder PJ
J Immunol; 2003 Dec; 171(12):6968-75. PubMed ID: 14662905
[TBL] [Abstract][Full Text] [Related]
7. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.
Shankar P; Russo M; Harnisch B; Patterson M; Skolnik P; Lieberman J
Blood; 2000 Nov; 96(9):3094-101. PubMed ID: 11049989
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
9. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T
Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229
[TBL] [Abstract][Full Text] [Related]
10. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
11. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
mBio; 2016 May; 7(3):. PubMed ID: 27247230
[TBL] [Abstract][Full Text] [Related]
12. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
López M; Soriano V; Rallón N; Cascajero A; González-Lahoz J; Benito JM
Eur J Immunol; 2008 Jun; 38(6):1548-58. PubMed ID: 18421792
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cellular immune responses in subjects chronically infected with HIV type 1.
Fu TM; Dubey SA; Mehrotra DV; Freed DC; Trigona WL; Adams-Muhler L; Clair JH; Evans TG; Steigbigel R; Jacobson JM; Goepfert PA; Mulligan MJ; Kalams SA; Rinaldo C; Zhu L; Cox KS; Guan L; Long R; Persaud N; Caulfield MJ; Sadoff JC; Emini EA; Thaler S; Shiver JW
AIDS Res Hum Retroviruses; 2007 Jan; 23(1):67-76. PubMed ID: 17263635
[TBL] [Abstract][Full Text] [Related]
14. Significance of the detection of HIV-1 gag- and/or pol-CD8/A2 T-lymphocytes in HIV-patients.
Wu R; Owen GC; Liu T; Shen GQ; Morris RI
Immunol Lett; 2005 Apr; 98(1):73-81. PubMed ID: 15790511
[TBL] [Abstract][Full Text] [Related]
15. Not all tetramer binding CD8+ T cells can produce cytokines and chemokines involved in the effector functions of virus-specific CD8+ T lymphocytes in HIV-1 infected children.
Scott-Algara D; Buseyne F; Porrot F; Corre B; Bellal N; Rouzioux C; Blanche S; Riviere Y
J Clin Immunol; 2005 Jan; 25(1):57-67. PubMed ID: 15742158
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children.
Scott ZA; Beaumier CM; Sharkey M; Stevenson M; Luzuriaga K
J Immunol; 2003 Jun; 170(11):5786-92. PubMed ID: 12759463
[TBL] [Abstract][Full Text] [Related]
17. CD8(+) T-cell gamma interferon production specific for human immunodeficiency virus type 1 (HIV-1) in HIV-1-infected subjects.
Huang XL; Fan Z; Kalinyak C; Mellors JW; Rinaldo CR
Clin Diagn Lab Immunol; 2000 Mar; 7(2):279-87. PubMed ID: 10702505
[TBL] [Abstract][Full Text] [Related]
18. CD8+ T Cell Breadth and Ex Vivo Virus Inhibition Capacity Distinguish between Viremic Controllers with and without Protective HLA Class I Alleles.
Koofhethile CK; Ndhlovu ZM; Thobakgale-Tshabalala C; Prado JG; Ismail N; Mncube Z; Mkhize L; van der Stok M; Yende N; Walker BD; Goulder PJR; Ndung'u T
J Virol; 2016 Aug; 90(15):6818-6831. PubMed ID: 27194762
[TBL] [Abstract][Full Text] [Related]
19. T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.
Giovannetti A; Pierdominici M; Mazzetta F; Salemi S; Marziali M; Kuonen D; Iebba F; Lusi EA; Cossarizza A; Aiuti F
Clin Exp Immunol; 2001 Apr; 124(1):21-31. PubMed ID: 11359439
[TBL] [Abstract][Full Text] [Related]
20. Functional restoration of human immunodeficiency virus and Epstein-Barr virus-specific CD8(+) T cells during highly active antiretroviral therapy is associated with an increase in CD4(+) T cells.
Kostense S; Otto SA; Knol GJ; Manting EH; Nanlohy NM; Jansen C; Lange JM; van Oers MH; Miedema F; van Baarle D
Eur J Immunol; 2002 Apr; 32(4):1080-9. PubMed ID: 11920575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]